137 related articles for article (PubMed ID: 30456833)
1. Standardized extract of Erythrina velutina Willd. attenuates schizophrenia-Like behaviours and oxidative parameters in experimental animal models.
Dias KCF; de Almeida JC; Vasconcelos LC; Patrocínio MLV; Barbosa TM; Ximenes NC; Leitão APA; Louchard BO; Pimenta ATÁ; Pinto FDCL; Leal LKAM; Honório Junior JER; Vasconcelos SMM
J Pharm Pharmacol; 2019 Mar; 71(3):379-389. PubMed ID: 30456833
[TBL] [Abstract][Full Text] [Related]
2. Ethanolic extract of Erythrina velutina Willd ameliorate schizophrenia-like behavior induced by ketamine in mice.
Ximenes NC; Dos Santos Júnior MA; Vasconcelos GS; Dias KCF; Jucá MM; Silva AH; Leal LKAM; Viana GSB; de Sousa FCF; Vasconcelos SMM
J Complement Integr Med; 2018 Oct; 16(2):. PubMed ID: 30315736
[TBL] [Abstract][Full Text] [Related]
3. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
[TBL] [Abstract][Full Text] [Related]
4. Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms.
Ben-Azu B; Aderibigbe AO; Eneni AO; Ajayi AM; Umukoro S; Iwalewa EO
Neurochem Res; 2018 Sep; 43(9):1745-1755. PubMed ID: 29956036
[TBL] [Abstract][Full Text] [Related]
5. Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences.
Sampaio LRL; Cysne Filho FMS; de Almeida JC; Diniz DDS; Patrocínio CFV; de Sousa CNS; Patrocínio MCA; Macêdo D; Vasconcelos SMM
Neuroscience; 2018 Mar; 373():72-81. PubMed ID: 29337238
[TBL] [Abstract][Full Text] [Related]
6. Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice.
Ben-Azu B; Aderibigbe AO; Ajayi AM; Eneni AO; Umukoro S; Iwalewa EO
Brain Res Bull; 2018 May; 139():292-306. PubMed ID: 29548911
[TBL] [Abstract][Full Text] [Related]
7. Ketamine potentiates oxidative stress and influences behavior and inflammation in response to lipolysaccharide (LPS) exposure in early life.
Réus GZ; Simões LR; Colpo GD; Scaini G; Oses JP; Generoso JS; Prossin AR; Kaddurah-Daouk R; Quevedo J; Barichello T
Neuroscience; 2017 Jun; 353():17-25. PubMed ID: 28433652
[TBL] [Abstract][Full Text] [Related]
8. The preventive effects of ascorbic acid supplementation on locomotor and acetylcholinesterase activity in an animal model of schizophrenia induced by ketamine.
Damazio LS; Silveira FR; Canever L; Castro AA; Estrela JM; Budni J; Zugno AI
An Acad Bras Cienc; 2017; 89(2):1133-1141. PubMed ID: 28513779
[TBL] [Abstract][Full Text] [Related]
9. Evidence for protective effect of lipoic acid and desvenlafaxine on oxidative stress in a model depression in mice.
Silva MC; de Sousa CN; Gomes PX; de Oliveira GV; Araújo FY; Ximenes NC; da Silva JC; Vasconcelos GS; Leal LK; Macêdo D; Vasconcelos SM
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():142-8. PubMed ID: 26265141
[TBL] [Abstract][Full Text] [Related]
10. Effects of standard ethanolic extract from Erythrina velutina in acute cerebral ischemia in mice.
Rodrigues FTS; de Sousa CNS; Ximenes NC; Almeida AB; Cabral LM; Patrocínio CFV; Silva AH; Leal LKAM; Honório Júnior JER; Macedo D; Vasconcelos SMM
Biomed Pharmacother; 2017 Dec; 96():1230-1239. PubMed ID: 29174035
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways.
Ben-Azu B; Omogbiya IA; Aderibigbe AO; Umukoro S; Ajayi AM; Iwalewa EO
Brain Res Bull; 2018 May; 139():114-124. PubMed ID: 29425796
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic-like effect of chronic treatment with Erythrina velutina extract in the elevated plus-maze test.
Raupp IM; Sereniki A; Virtuoso S; Ghislandi C; Cavalcanti E Silva EL; Trebien HA; Miguel OG; Andreatini R
J Ethnopharmacol; 2008 Jul; 118(2):295-9. PubMed ID: 18550307
[TBL] [Abstract][Full Text] [Related]
13. Changes in behavioural parameters, oxidative stress and neurotrophins in the brain of adult offspring induced to an animal model of schizophrenia: The effects of FA deficient or FA supplemented diet during the neurodevelopmental phase.
Canever L; Freire TG; Mastella GA; Damázio L; Gomes S; Fachim I; Michels C; Carvalho G; Godói AK; Peterle BR; Gava FF; Valvassori SS; Budni J; Quevedo J; Zugno AI
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():52-64. PubMed ID: 29782958
[TBL] [Abstract][Full Text] [Related]
14. Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia.
Becker A; Peters B; Schroeder H; Mann T; Huether G; Grecksch G
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):687-700. PubMed ID: 12787858
[TBL] [Abstract][Full Text] [Related]
15. Cocaine-induced status epilepticus and death generate oxidative stress in prefrontal cortex and striatum of mice.
Macêdo DS; Vasconcelos SM; Andrade-Neto M; Belchior LD; Honório Júnior JE; Gonçalves DO; Fonteles MM; Silva MI; Aguiar LM; Viana GS; de Sousa FC
Neurochem Int; 2010 Jan; 56(1):183-7. PubMed ID: 19822180
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant, antioxidant and neurotrophic properties of the standardized extract of Cocos nucifera husk fiber in mice.
Lima EB; de Sousa CN; Vasconcelos GS; Meneses LN; E Silva Pereira YF; Ximenes NC; Santos Júnior MA; Matos NC; Brito R; Miron D; Leal LK; Macêdo D; Vasconcelos SM
J Nat Med; 2016 Jul; 70(3):510-21. PubMed ID: 26857134
[TBL] [Abstract][Full Text] [Related]
17. The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia.
Réus GZ; Becker IRT; Scaini G; Petronilho F; Oses JP; Kaddurah-Daouk R; Ceretta LB; Zugno AI; Dal-Pizzol F; Quevedo J; Barichello T
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():55-63. PubMed ID: 29030243
[TBL] [Abstract][Full Text] [Related]
18. Morin decreases cortical pyramidal neuron degeneration via inhibition of neuroinflammation in mouse model of schizophrenia.
Ben-Azu B; Aderibigbe AO; Ajayi AM; Eneni AO; Omogbiya IA; Owoeye O; Umukoro S; Iwalewa EO
Int Immunopharmacol; 2019 May; 70():338-353. PubMed ID: 30852289
[TBL] [Abstract][Full Text] [Related]
19. Ketamine Exhibits Different Neuroanatomical Profile After Mammalian Target of Rapamycin Inhibition in the Prefrontal Cortex: the Role of Inflammation and Oxidative Stress.
Abelaira HM; Réus GZ; Ignácio ZM; Dos Santos MAB; de Moura AB; Matos D; Demo JP; da Silva JBI; Danielski LG; Petronilho F; Carvalho AF; Quevedo J
Mol Neurobiol; 2017 Sep; 54(7):5335-5346. PubMed ID: 27590136
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats.
Kozela E; Krawczyk M; Kos T; Juknat A; Vogel Z; Popik P
Mol Neurobiol; 2020 Mar; 57(3):1733-1747. PubMed ID: 31823199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
